Sample | Title | Value | Rank |
GSM16943 | Wild Type Control Set A | 2.6 | 9 |
GSM18491 | WT Control Sample B | 2 | 9 |
GSM18492 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample A | 4.7 | 14 |
GSM18493 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 1 Hr Treatment Sample B | 5.8 | 19 |
GSM18494 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample A | 7.7 | 20 |
GSM18495 | MDA-MB-231 Breast Cancer Cells Stably Expressing wild-type ERa 2 Hr Treatment Sample B | 2.3 | 10 |
GSM18496 | MDA-MB-231 Breast Cancer Cells Stably Expressing Mutant ERa LQ Control Sample A | 4.8 | 13 |
GSM18497 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ Sample B | 3.3 | 15 |
GSM18498 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample A | 7.9 | 18 |
GSM18499 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 1 Hr Treatment of 10 nM E2 Sample B | 2.1 | 8 |
GSM18500 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample A | 7.5 | 18 |
GSM18501 | MDA-MB-231 Breast Cancer Cells Stably Expressing mutant ERa LQ 2 Hr Treatment of 10 nM E2 Sample B | 2.8 | 10 |